Publications by authors named "V Eichwald"

Article Synopsis
  • Glioblastoma multiforme (GBM) is a serious brain tumor found in adults with a short survival time of about 15 months.
  • A protein called CD44 is found in high amounts in this type of tumor and helps cancer cells move and grow.
  • Researchers discovered that CD44 in certain immune cells (myeloid cells) is important for GBM cells to invade nearby brain tissue, affecting how serious the disease can be.
View Article and Find Full Text PDF

Serum calcium isotopes (δCa) have been suggested as a non-invasive and sensitive Ca balance marker. Quantitative δCa changes associated with Ca flux across body compartment barriers relative to the dietary Ca and the correlation of δCa with bone histology are unknown. We analyzed Ca and δCa by mass-spectrometry in rats after two weeks of standard-Ca-diet (0.

View Article and Find Full Text PDF

Purpose: To evaluate and compare the material characteristics of a novel type of radiopaque doxorubicin-loaded microsphere (V-100) with radiopaque and non-radiopaque doxorubicin-loaded microspheres.

Materials And Methods: The prototype V-100 featuring inherent radiopacity and three available commercial controls (DC-Bead-LUMI™-70-150, Embozene-Tandem™-100 and DC-Bead™-M1) were analyzed before and after doxorubicin loading (37.5 mg doxorubicin/1 ml microspheres) in suspension with aqua and/or aqua/iodixanol-320.

View Article and Find Full Text PDF

Purpose: To investigate the novel zein-based non-adhesive precipitating liquid embolic HEI.

Materials And Methods: Zein-based liquid embolics are an own class of embolization material. In this study, HEI, a novel zein-based liquid embolic, was investigated.

View Article and Find Full Text PDF

Purpose: To investigate radiopacity, size and size calibration, morphology, and vascular distribution of inherently radiopaque microspheres in vitro and in a pig embolization model.

Materials And Methods: We compared three types of microspheres: DCBead™ (size 100-300 µm) and Embozene™ (250 µm) as clinically established microspheres, and the prototype Visible (250 µm) that contains additional radiopaque material. Size and size calibration of microspheres were examined by laser diffraction.

View Article and Find Full Text PDF